Hookah is a common tobacco product, especially among youth. A research team aimed to better understand the effects of hookah on thrombogenesis. Lead author Fadi Khasawneh, B.Pharm, PhD, answered our...
In this video, Andrew Freeman, MD, leads a panel discussion around nutritional counseling in the cardiology clinic. Panelists include Emilio Ros, MD, PhD; Monica Aggarwal, MD; Robert Ostfeld, MD, MSc; James...
In part 5 of our series on lipid management, Paul Jellinger, MD, MACE, highlights the importance of coronary artery calcium score as a risk factor for ASCVD and its role in diagnosis and treatment of...
In part 2 of our series on lipid management, Dr Paul Jellinger explains the answer to the quiz question from part 1, the AACE lipid guidelines, and the role of renal disease in managing this patient. ...
New data are shedding light on the use of NOACs among patients with atrial fibrillation and obesity. Robert Giugliano, MD, explains how he hopes the new research will impact future guideline updates.
In this video, David Conen, MD, MPH, provides insight into the results of the Swiss Atrial Fibrillation Cohort (Swiss-AF) trial and what they reveal about the incidence of clinically silent brain infarcts...
In this video, Deepak Bhatt, MD, MPH, overviews the findings from the eicosapentaenoic acid (EPA) analysis of the REDUCE-IT trial and what impact the results may have on the future of cardiovascular...
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient...
